Relationship between serum progesterone (P) levels and pregnancy outcome: lessons from artificial cycles when using vagi
- PDF / 162,787 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 11 Downloads / 204 Views
LETTER TO EDITOR
Relationship between serum progesterone (P) levels and pregnancy outcome: lessons from artificial cycles when using vaginal natural micronized progesterone Elena Labarta 1 Received: 11 May 2020 / Accepted: 16 June 2020 # Springer Science+Business Media, LLC, part of Springer Nature 2020
Luteal phase management during assisted reproduction is increasingly pursued for its potential to contribute to positive reproductive outcomes. Recent publications indicate that using vaginal natural micronized progesterone in artificial cycles leads to serum P levels in the mid luteal phase that are associated with pregnancy outcome after embryo transfer [1–5]. Two prospective clinical trials have been performed to date, including almost 1400 patients. These trials were blinded to the result of serum P on the day of embryo transfer, and accordingly, no changes in the dose of P for luteal phase support (LPS) were performed during the study period; thus, the association between serum P levels and ongoing and live birth rates could be analyzed [5, 6]. The critical threshold of serum P was around 9 ng/mL. Patients who exhibited lower levels showed a significantly lower ongoing pregnancy rate and higher miscarriage rate. These findings, combined with retrospective analyses [1–4], suggest that—regardless of uterine P levels—a minimum level of serum P is required to optimize clinical outcome. In contrast, one recent study concluded that P levels do not influence outcomes, independent of a 10-ng/mL threshold [7]. An explanation for this finding is that patients who had low levels (< 8 ng/mL) received extra doses of progesterone. As such, the authors were carrying out an intervention to prevent low levels that may promote poor outcomes. These results demonstrate a critical point: if monitoring of serum P is conducted and LPS is modified accordingly, clinicians can overcome the problem of patients having inadequate levels of progesterone that are associated with poorer outcomes [8]. Notably, these results can be extrapolated only to artificial cycles and, most importantly, use of vaginal natural-like * Elena Labarta [email protected] 1
Human Reproduction Department, IVI RMA, Plaza Policía Local, 3, 46015 Valencia, Spain
progesterone, as preferred by many clinicians worldwide [9]. Indeed, the pharmacokinetics and pharmacodynamics of vaginally administered P differ from those of the intramuscular, subcutaneous, or oral administration routes [10]. For this reason, studies examining the role of serum P on pregnancy outcome cannot be compared when using different routes of administration. Vaginal delivery of P leads to higher uterine P levels due to the first uterine pass effect [11] and lower serum P levels when compared with parenteral administration. Importantly, the lower bioavailability with vaginal preparations does not seem to exert a reduced biologic effect [12, 13]. Whether there is a critical minimum threshold when using parenteral preparations needs to be further studied. Such a threshold might be expected t
Data Loading...
